Colonization, safety, and tolerability study of the Streptococcus salivarius 24SMBc nasal spray for its application in upper respiratory tract infections

European Journal of Clinical Microbiology and Infectious Diseases

Volumn 34, Issue 10, 2015, Pages 2075-2080

  Santagati, M ^a   Scillato, M ^a   Muscaridola, N ^a   Metoldo, V ^a   La Mantia, I ^a   Stefani, S ^a  

^a UNIVERSITY OF CATANIA   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIBIOTIC AGENT; NOSE SPRAY; PROBIOTIC AGENT; ANTIINFECTIVE AGENT;

ADULT; ANTIBIOTIC THERAPY; ARTICLE; BACTERIAL COLONIZATION; COLONY FORMING UNIT; DRUG SAFETY; DRUG TOLERABILITY; FEMALE; HUMAN; MALE; MICROFLORA; MIDDLE AGED; NASOPHARYNX; NORMAL HUMAN; PILOT STUDY; PRIORITY JOURNAL; RANDOM AMPLIFIED POLYMORPHIC DNA; STREPTOCOCCUS SALIVARIUS; UPPER RESPIRATORY TRACT; UPPER RESPIRATORY TRACT INFECTION; YOUNG ADULT; DRUG EFFECTS; RESPIRATORY TRACT INFECTIONS; STREPTOCOCCAL INFECTIONS; STREPTOCOCCUS;

ADULT; ANTI-BACTERIAL AGENTS; FEMALE; HUMANS; MALE; MIDDLE AGED; NASAL SPRAYS; PILOT PROJECTS; PROBIOTICS; RESPIRATORY TRACT INFECTIONS; STREPTOCOCCAL INFECTIONS; STREPTOCOCCUS;

EID: 84941415769     PISSN: 09349723     EISSN: 14354373     Source Type: Journal    
DOI: 10.1007/s10096-015-2454-2     Document Type: Article

References (31)

1. Lenoir-Wijnkoop I, Sanders ME, Cabana MD, Caglar E, Corthier G, Rayes N, Sherman PM, Timmerman HM, Vaneechoutte M, Van Loo J, Wolvers DA (2007) Probiotic and prebiotic influence beyond the intestinal tract. Nutr Rev 11(65):469–489
2. Gareau MG, Sherman PM, Walker WA (2010) Probiotics and the gut microbiota in intestinal health and disease. Nat Rev Gastroenterol Hepatol 7(9):503–514, review
3. Ashraf R, Shah NP (2014) Immune system stimulation by probiotic microorganisms. Crit Rev Food Sci Nutr 54:938–956
4. Koboziev I, Reinoso Webb C, Furr KL, Grisham MB (2014) Role of the enteric microbiota in intestinal homeostasis and inflammation. Free Radic Biol Med 68:122–133
5. Liu S, Hu P, Du X, Zhou T, Pei X (2013) Lactobacillus rhamnosus GG supplementation for preventing respiratory infections in children: a meta-analysis of randomized, placebo-controlled trials. Indian Pediatr 50(4):377–381
6. Cohen R, Martin E, de La Rocque F, Thollot F, Pecquet S, Werner A, Boucherat M, Varon E, Bingen E, Levy C (2013) Probiotics and prebiotics in preventing episodes of acute otitis media in high-risk children: a randomized, double-blind, placebo-controlled study. Pediatr Infect Dis J 32(8):810–814
7. Hatakka K, Blomgren K, Pohjavuori S, Kaijalainen T, Poussa T, Leinonen M, Korpela R, Pitkäranta A (2007) Treatment of acute otitis media with probiotics in otitis-prone children a double-blind, placebo-controlled randomised study. Clin Nutr 26(3):314–321
8. Wescombe PA, Hale JD, Heng NC, Tagg JR (2012) Developing oral probiotics from Streptococcus salivarius. Future Microbiol 7:1355–1371
9. Monasta L, Ronfani L, Marchetti F, Montico M, Vecchi Brumatti L, Bavcar A, Grasso D, Barbiero C, Tamburlini G (2012) Burden of disease caused by otitis media: systematic review and global estimates. PLoS One 7:e36226
10. Lieberthal AS, Carroll AE, Chonmaitree T, Ganiats TG, Hoberman A, Jackson MA, Joffe MD, Miller DT, Rosenfeld RM, Sevilla XD, Schwartz RH, Thomas PA, Tunkel DE; American Academy of Pediatrics Subcommittee on Management of Acute Otitis Media (2013) The diagnosis and management of acute otitis media. Pediatrics 131:e964–e999
11. Marchisio P, Claut L, Rognoni A, Esposito S, Passali D, Bellussi L, Drago L, Pozzi G, Mannelli S, Schito G, Principi N (2003) Differences in nasopharyngeal bacterial flora in children with nonsevere recurrent acute otitis media and chronic otitis media with effusion: implications for management. Pediatr Infect Dis J 22:262–268
12. John M, Dunne EM, Licciardi PV, Satzke C, Wijburg O, Robins-Browne RM, O’Leary S (2013) Otitis media among high-risk populations: can probiotics inhibit Streptococcus pneumoniae colonisation and the risk of disease? Eur J Clin Microbiol Infect Dis 32(9):1101–1110, review
13. Tagg JR (2004) Prevention of streptococcal pharyngitis by anti-Streptococcus pyogenes bacteriocin-like inhibitory substances (BLIS) produced by Streptococcus salivarius. Indian J Med Res 119(Suppl):13–16
14. Burton JP, Chilcott CN, Moore CJ, Speiser G, Tagg JR (2006) A preliminary study of the effect of probiotic Streptococcus salivarius K12 on oral malodour parameters. J Appl Microbiol 100(4):754–764
15. Santagati M, Scillato M, Patanè F, Aiello C, Stefani S (2012) Bacteriocin-producing oral streptococci and inhibition of respiratory pathogens. FEMS Immunol Med Microbiol 65(1):23–31
16. Stol K, Verhaegh SJ, Graamans K, Engel JA, Sturm PD, Melchers WJ, Meis JF, Warris A, Hays JP, Hermans PW (2013) Microbial profiling does not differentiate between childhood recurrent acute otitis media and chronic otitis media with effusion. Int J Pediatr Otorhinolaryngol 77(4):488–493
17. Célind J, Södermark L, Hjalmarson O (2014) Adherence to treatment guidelines for acute otitis media in children. The necessity of an effective strategy of guideline implementation. Int J Pediatr Otorhinolaryngol 78(7):1128–1132
18. Tagg JR, Bannister LV (1979) “Fingerprinting” beta-haemolytic streptococci by their production of and sensitivity to bacteriocine-like inhibitors. J Med Microbiol 12:397–411
19. Truong TL, Ménard C, Mouton C, Trahan L (2000) Identification of mutans and other oral streptococci by random amplified polymorphic DNA analysis. J Med Microbiol 49:63–71
20. Conticello S, Saita V, La Mantia I, Ferlito S (1989) Endoscopy of the eustachian tube: use of the fiberscope and the telescope. Arch Otorhinolaryngol 246:256–258, Sprinter-Verlag Ed
21. Serra A, Grillo C, La Mantia I, Cipri R, Vancheri M, Saita V (1992) Naso-pharyngo-laryngoscopie et rhinomanométrie avec endoscope flexible dans l’étude de l’hypertrophie adénoïde. Acta Endoscopica Belg 22:381–384
22. Human Microbiome Project Consortium (2012) Structure, function and diversity of the healthy human microbiome. Nature 486:207–214
23. Aas JA, Paster BJ, Stokes LN, Olsen I, Dewhirst FE (2005) Defining the normal bacterial flora of the oral cavity. J Clin Microbiol 43(11):5721–5732
24. Soccol CR, Porto de Souza Vandenberghe L, Spier MR, Pedroni Medeiros AB, Yamaguishi CT, De Dea Lindner J, Pandey A, Thomaz-Soccol V (2010) The potential of probiotics: a review. Food Technol Biotech 48(4):413–434
25. Caglar E, Kargul B, Tanboga I (2005) Bacteriotherapy and probiotics’ role on oral health. Oral Dis 11(3):131–137
26. Di Pierro F, Colombo M, Zanvit A, Risso P, Rottoli AS (2014) Use of Streptococcus salivarius K12 in the prevention of streptococcal and viral pharyngotonsillitis in children. Drug Healthc Patient Saf 6:15–20
27. Walls T, Power D, Tagg J (2003) Bacteriocin-like inhibitory substance (BLIS) production by the normal flora of the nasopharynx: potential to protect against otitis media? J Med Microbiol 52(Pt 9):829–833
28. Roos K, Håkansson EG, Holm S (2001) Effect of recolonisation with “interfering” alpha streptococci on recurrences of acute and secretory otitis media in children: randomised placebo controlled trial. BMJ 322(7280):210–212
29. Tano K, Grahn Håkansson E, Holm SE, Hellström S (2002) A nasal spray with alpha-haemolytic streptococci as long term prophylaxis against recurrent otitis media. Int J Pediatr Otorhinolaryngol 62(1):17–23
30. Skovbjerg S, Roos K, Holm SE, Grahn Håkansson E, Nowrouzian F, Ivarsson M, Adlerberth I, Wold AE (2009) Spray bacteriotherapy decreases middle ear fluid in children with secretory otitis media. Arch Dis Child 94(2):92–98
31. Gao Z, Kang Y, Yu J, Ren L (2014) Human pharyngeal microbiome may play a protective role in respiratory tract infections. Genomics Proteomics Bioinformatics 12(3):144–150